abstract |
The invention relates to a novel peptide, fusion proteins and polypeptides containing said peptide, test kits and a method for detecting the peptide, coding nucleic acids and pharmaceutical compositions which contain the peptide or are based on the coding nucleic acid. The peptide serves as a marker for diagnostically detecting inflammatory and/or excitation-inhibitory processes and diseases of the nervous system and as a basis for pharmaceutical compositions for treating diseases of the nervous system or for pharmaceutical compositions having an anaesthetic effect. |